In cancer, collagen binding to DDR1 receptors triggers signals that help tumor cells spread and invade other tissues, which is a key step in cancer progression.

This study talks generally about how collagen interacts with cells and how it can be used in medicine, but it doesn’t mention cancer, DDR1, or the specific pathways that drive cancer spread, so it can’t confirm the claim.